Antiphospholipid syndrome Antisynthetase Aldostérone Anticorps spécifique des myosites Aldosterone Myositis Anti-interleukin-6 Male Adult Acute Kidney Injury/epidemiology/etiology Lysosomal storage diseases Deep immune profiling Dermatomyositis Female Cancer Antibodies Analyses multidimensionnelles Cardio-oncology Anti-Mi2 Anti-drug antibodies Adjudication Anti-synthetase syndrome Interstitial lung disease Anti-agalsidase antibodies Biomarker Inclusion body myositis Abnormal movement Autoimmunity Amyotrophic lateral sclerosis Skeletal muscle Biomarqueurs Mass cytometry Adeno-associated virus Arthritis AAV vectors Anti-IgE IgG Outcome measures Gene therapy Myopathy Systems biology Anti-MDA5 autoantibodies Anticorps anti-agalsidase AAV vector Antisynthétase Biopsy IBM Anémie hémolytique Inflammation Idiopathic inflammatory myopathies AAV humoral immunity Anti‐mitochondrial antibodies Data integration Fabry disease Antisynthetase syndrome Immune checkpoint inhibitors Acid-alpha-glucosidase Adeno-associated vector IMNM Prognosis Pharmacology AAV antibody Inflammatory myopathy Sphingosine-1-phosphate Muscle Immunotherapy Multidisciplinarity Biomarkers Aged Humans Polymyositis Bioelectrical impedance analysis Assisted communication devices Adeno-associated virus vector Autoimmune diseases Auto-antibodies Autoantibodies Antibody responses Auto-immunité B cell homeostasis Myositis and muscle disease Autoantibody Animals Interferon B-lymphocyte COVID-19 Myocarditis Dependovirus/genetics/immunology Amyotrophy DM Auto‐antibodies Inborn errors of metabolism Machine learning Case reports Middle Aged Cytokines Active Adverse drug reactions AAV Adolescence Agalsidase